These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


220 related items for PubMed ID: 11854433

  • 21. N1-dansyl-spermine and N1-(n-octanesulfonyl)-spermine, novel glutamate receptor antagonists: block and permeation of N-methyl-D-aspartate receptors.
    Chao J, Seiler N, Renault J, Kashiwagi K, Masuko T, Igarashi K, Williams K.
    Mol Pharmacol; 1997 May; 51(5):861-71. PubMed ID: 9145925
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Structural conservation of ion conduction pathways in K channels and glutamate receptors.
    Wood MW, VanDongen HM, VanDongen AM.
    Proc Natl Acad Sci U S A; 1995 May 23; 92(11):4882-6. PubMed ID: 7761417
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The activation gate and gating mechanism of the NMDA receptor.
    Chang HR, Kuo CC.
    J Neurosci; 2008 Feb 13; 28(7):1546-56. PubMed ID: 18272676
    [Abstract] [Full Text] [Related]

  • 27. Roles of N-methyl-D-aspartate receptors and D-amino acids in cancer cell viability.
    Du S, Sung YS, Wey M, Wang Y, Alatrash N, Berthod A, MacDonnell FM, Armstrong DW.
    Mol Biol Rep; 2020 Sep 13; 47(9):6749-6758. PubMed ID: 32892308
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. NMDA channel gating is influenced by a tryptophan residue in the M2 domain but calcium permeation is not altered.
    Buck DP, Howitt SM, Clements JD.
    Biophys J; 2000 Nov 13; 79(5):2454-62. PubMed ID: 11053122
    [Abstract] [Full Text] [Related]

  • 30. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
    Chen PE, Geballe MT, Stansfeld PJ, Johnston AR, Yuan H, Jacob AL, Snyder JP, Traynelis SF, Wyllie DJ.
    Mol Pharmacol; 2005 May 13; 67(5):1470-84. PubMed ID: 15703381
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Memantine selectively blocks extrasynaptic NMDA receptors in rat substantia nigra dopamine neurons.
    Wu YN, Johnson SW.
    Brain Res; 2015 Apr 07; 1603():1-7. PubMed ID: 25656790
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition.
    Misiachna A, Konecny J, Kolcheva M, Ladislav M, Prchal L, Netolicky J, Kortus S, Zahumenska P, Langore E, Novak M, Hemelikova K, Hermanova Z, Hrochova M, Pelikanova A, Odvarkova J, Pejchal J, Kassa J, Zdarova Karasova J, Korabecny J, Soukup O, Horak M.
    Biomed Pharmacother; 2024 Sep 07; 178():117201. PubMed ID: 39053419
    [Abstract] [Full Text] [Related]

  • 36. Specific sites within the ligand-binding domain and ion channel linkers modulate NMDA receptor gating.
    Talukder I, Borker P, Wollmuth LP.
    J Neurosci; 2010 Sep 01; 30(35):11792-804. PubMed ID: 20810899
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-D-aspartate receptors in nascent neocortical synapses.
    Mohrmann R, Köhr G, Hatt H, Sprengel R, Gottmann K.
    J Neurosci Res; 2002 May 01; 68(3):265-75. PubMed ID: 12111856
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.